AFP and hepatocellular carcinoma: In the subset cohort of HCC patients diagnosed at an early stage (AJCC stage I), the proportion of patients who underwent AFP testing remained higher in the black (79.5%) and other race (82.2%) groups than in the white patients group (78.0%) (Figure 1C).